Qin, Jiangxi – Trademark Portfolio

Entity Type: 01

Qin, Jiangxi holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include WOPHENPA. The owner is based in Guilin, Guangxi.

Tanxia Town, Lingchuan County

No. 81, Zhuantang Village

Guilin, Guangxi 541208 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WOPHENPA
WOPHENPA
Registered 2024
M&WBATH
M&WBATH
Abandoned 2023

Trademark Classifications

Qin, Jiangxi's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Qin, Jiangxi have?

Qin, Jiangxi has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Qin, Jiangxi file in?

Qin, Jiangxi files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Qin, Jiangxi's most well-known trademarks?

Qin, Jiangxi's registered trademark portfolio includes well-known marks such as WOPHENPA. These are among 1 currently registered trademark in the portfolio.

What is Qin, Jiangxi's trademark registration success rate?

Qin, Jiangxi has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.